Back
Rocket Pharmaceuticals Stock Price Chart
Unlock the power of "two-minute trades"
Learn how today!
Sell
11
RCKT
Rocket Pharmaceuticals
Last Price:
$11.15
Seasonality Move:
-13.12%
7 Day Trial
ALL ACCESS PASS
$
7
Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing slight selling pressure.
Rocket Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.21 | Sell |
| 20-day SMA: | 12.05 | Sell |
| 50-day SMA: | 13.84 | Sell |
| 200-day SMA: | 19.42 | Sell |
| 8-day EMA: | 11.99 | Sell |
| 20-day EMA: | 12.34 | Sell |
| 50-day EMA: | 13.72 | Sell |
| 200-day EMA: | 18.18 | Sell |
Rocket Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.51 | Sell |
| Relative Strength Index (14 RSI): | 33.62 | Sell |
| Chaikin Money Flow: | -646072 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.56 - 13.16) | Sell |
| Bollinger Bands (100): | (13.31 - 18.93) | Sell |
Rocket Pharmaceuticals Technical Analysis
| Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rocket Pharmaceuticals Stock
Is Rocket Pharmaceuticals Stock a Buy?
-
Rocket Pharmaceuticals share price is 11.14 while RCKT 8-day simple moving average is 12.21, which is a Sell signal.
-
The stock price of RCKT is 11.14 while Rocket Pharmaceuticals 20-day SMA is 12.05, which makes it a Sell.
-
Rocket Pharmaceuticals 50-day simple moving average is 13.84 while RCKT share price is 11.14, making it a Sell technically.
-
RCKT stock price is 11.14 and Rocket Pharmaceuticals 200-day simple moving average is 19.42, creating a Sell signal.
RCKT Technical Analysis vs Fundamental Analysis
Sell
11
Rocket Pharmaceuticals (RCKT)
is a Sell
Is Rocket Pharmaceuticals a Buy or a Sell?
-
Rocket Pharmaceuticals stock is rated a SellThe current Rocket Pharmaceuticals [RCKT] share price is $11.14. The Score for RCKT is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
Rocket Pharmaceuticals Stock Info
Market Cap:
1B
Price in USD:
11.14
Share Volume:
1.8M
Rocket Pharmaceuticals 52-Week Range
52-Week High:
31.47
52-Week Low:
10.88
Sell
11
Rocket Pharmaceuticals (RCKT)
is a Sell
Rocket Pharmaceuticals Share Price Forecast
-
What is the Rocket Pharmaceuticals stock price today?The Rocket Pharmaceuticals stock price is 11.14 USD today.
-
Will RCKT stock go up or go down?Rocket Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Rocket Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rocket Pharmaceuticals is overvalued.
Is Rocket Pharmaceuticals Stock a Buy?
-
Rocket Pharmaceuticals share price is 11.14 while RCKT 8-day exponential moving average is 11.99, which is a Sell signal.
-
The stock price of RCKT is 11.14 while Rocket Pharmaceuticals 20-day EMA is 12.34, which makes it a Sell.
-
Rocket Pharmaceuticals 50-day exponential moving average is 13.72 while RCKT share price is 11.14, making it a Sell technically.
-
RCKT stock price is 11.14 and Rocket Pharmaceuticals 200-day simple moving average is 18.18, creating a Sell signal.
Fundamental Analysis of Rocket Pharmaceuticals
Is Rocket Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.91 per share.
Technical Analysis of Rocket Pharmaceuticals
Should I short Rocket Pharmaceuticals stock?
-
RCKT Moving Average Covergence Divergence (MACD) indicator is -0.51, suggesting Rocket Pharmaceuticals is a Sell
-
Rocket Pharmaceuticals Relative Strength Index (RSI) is 33.62, which suggest Rocket Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Rocket Pharmaceuticals is (11.56 - 13.16), which suggest Rocket Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Rocket Pharmaceuticals is (13.31 - 18.93), which suggest Rocket Pharmaceuticals is a Sell
* Rocket Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.